Cytotoxicity assays. Rory D. de Vries, PhD 1. Viroscience lab, Erasmus MC, Rotterdam, the Netherlands

Similar documents
Micro 204. Cytotoxic T Lymphocytes (CTL) Lewis Lanier

Chapter 17B: Adaptive Immunity Part II

Scott Abrams, Ph.D. Professor of Oncology, x4375 Kuby Immunology SEVENTH EDITION

Bioassays for Quality Control of Cell & Gene Therapy Products

C. Incorrect! MHC class I molecules are not involved in the process of bridging in ADCC.

Adaptive Immunity: Specific Defenses of the Host

CD4 + CD25 high Foxp3 + T regulatory cells kill autologous CD8(+) and CD4(+) T cells using Fas/FasL- and Granzyme B- mediated pathways

Induction and Clearance of Latent HIV Infection:

RAISON D ETRE OF THE IMMUNE SYSTEM:

Cell Mediated Immunity CELL MEDIATED IMMUNITY. Basic Elements of Cell Mediated Immunity (CMI) Antibody-dependent cell-mediated cytotoxicity (ADCC)

Defensive mechanisms include :

Immunology Basics Relevant to Cancer Immunotherapy: T Cell Activation, Costimulation, and Effector T Cells

Immune response. This overview figure summarizes simply how our body responds to foreign molecules that enter to it.

Estimating primate effector T cell responses to DNA vaccination

1. Overview of Adaptive Immunity

The Adaptive Immune Responses

Innate and Cellular Immunology Control of Infection by Cell-mediated Immunity

Naive, memory and regulatory T lymphocytes populations analysis

chapter 17: specific/adaptable defenses of the host: the immune response

TCR, MHC and coreceptors

Adaptive Immune System

Third line of Defense

Adaptive (acquired) immunity. Professor Peter Delves University College London

Ex vivo Human Antigen-specific T Cell Proliferation and Degranulation Willemijn Hobo 1, Wieger Norde 1 and Harry Dolstra 2*

What to Measure, How to Measure It

MHC Tetramers and Monomers for Immuno-Oncology and Autoimmunity Drug Discovery

Shiv Pillai Ragon Institute, Massachusetts General Hospital Harvard Medical School

There are 2 major lines of defense: Non-specific (Innate Immunity) and. Specific. (Adaptive Immunity) Photo of macrophage cell

MCB 4211 Basic Immunology 2nd Exam; 10/26/17 Peoplesoft #:

Tumors arise from accumulated genetic mutations. Tumor Immunology (Cancer)

General Overview of Immunology. Kimberly S. Schluns, Ph.D. Associate Professor Department of Immunology UT MD Anderson Cancer Center

RAISON D ETRE OF THE IMMUNE SYSTEM:

Cellular Immune response. Jianzhong Chen, Ph.D Institute of immunology, ZJU

Clinical Translation of Immunotherapy using WT1 and CMV specific TCR Gene Transfer

IMMUNE EFFECTOR MECHANISMS. Cell-Mediated Reactions

LAB 1, Immunology. Laboratory manual Immunology and Infection Biology Biomedicine course Autumn 2007

Rapid perforin upregulation directly ex vivo by CD8 + T cells is a defining characteristic of HIV elite controllers

Attribution: University of Michigan Medical School, Department of Microbiology and Immunology

7-AAD/CFSE Cell-Mediated Cytotoxicity Assay Kit

Supplementary Data Table of Contents:

CELLULAR AND MOLECULAR REQUIREMENTS FOR REJECTION OF B16 MELANOMA IN THE SETTING OF REGULATORY T CELL DEPLETION AND HOMEOSTATIC PROLIFERATION

Determinants of Immunogenicity and Tolerance. Abul K. Abbas, MD Department of Pathology University of California San Francisco

Immunity to Viruses. Patricia Fitzgerald-Bocarsly September 25, 2008

SUPPLEMENTARY INFORMATION

NK mediated Antibody Dependent Cellular Cytotoxicity in HIV infections

TITLE: Development of Antigen Presenting Cells for adoptive immunotherapy in prostate cancer

The Immune System. These are classified as the Innate and Adaptive Immune Responses. Innate Immunity

General Biology. A summary of innate and acquired immunity. 11. The Immune System. Repetition. The Lymphatic System. Course No: BNG2003 Credits: 3.

Supplemental Methods. CD107a assay

Practical Solution: presentation to cytotoxic T cells. How dendritic cells present antigen. How dendritic cells present antigen

Introduction to Immune System

HACKING HIV: CREATING AND ASSESSING A NOVEL CTL-BASED HIV-1 VACCINE

Third line of Defense. Topic 8 Specific Immunity (adaptive) (18) 3 rd Line = Prophylaxis via Immunization!

Commercially available HLA Class II tetramers (Beckman Coulter) conjugated to

Cellular biomarkers of T lymphocyte func6on. Michael Be9s University of Pennsylvania Department of Microbiology

Unit 6: Adaptive Immunity. Adaptive Immunity (Humoral Immunity; Cell-Mediated Immunity; Immunodeficiency; Hypersensitivity)

Adaptive Immunity: Humoral Immune Responses

7/14/2014. Multiple immune effector mechanisms contribute to protection influenza. What is a correlate of protection?

Human Cytomegalovirus Latency-Associated Proteins Elicit Immune-Suppressive IL-10 Producing CD4 + T Cells

The Major Histocompatibility Complex (MHC)

Therapeutic Cancer Vaccines

Medical Virology Immunology. Dr. Sameer Naji, MB, BCh, PhD (UK) Head of Basic Medical Sciences Dept. Faculty of Medicine The Hashemite University

Review Antigen-specific cytometry Andreas Thiel and Andreas Radbruch

EBV Infection and Immunity. Andrew Hislop Institute for Cancer Studies University of Birmingham

Lecture 4. T lymphocytes

7.012 Quiz 3 Answers

Cover Page. The handle holds various files of this Leiden University dissertation.

Lecture 6. Burr BIO 4353/6345 HIV/AIDS. Tetramer staining of T cells (CTL s) Andrew McMichael seminar: Background

08/02/59. Tumor Immunotherapy. Development of Tumor Vaccines. Types of Tumor Vaccines. Immunotherapy w/ Cytokine Gene-Transfected Tumor Cells

Review Article Profile of a Serial Killer: Cellular and Molecular Approaches to Study Individual Cytotoxic T-Cells following Therapeutic Vaccination

Out-of-sequence signal 3 as a mechanism for virusinduced immune suppression of CD8 T cell responses

Memory T cells established by seasonal human influenza A infection cross-react with avian influenza A (H5N1) in healthy individuals

Detailed step-by-step operating procedures for NK cell and CTL degranulation assays

TITLE: Development of Antigen Presenting Cells for adoptive immunotherapy in prostate cancer

Immunological Monitoring of Cancer Vaccine Clinical Trials:

Cellular Pathology of immunological disorders

Viral Persistence Alters CD8 T-Cell Immunodominance and Tissue Distribution and Results in Distinct Stages of Functional Impairment

staining and flow cytometry

Antigen presenting cells

Vaccine Design: A Statisticans Overview

M.Sc. III Semester Biotechnology End Semester Examination, 2013 Model Answer LBTM: 302 Advanced Immunology

Supplementary Figure 1. Example of gating strategy

TITLE: Development of Antigen Presenting Cells for adoptive immunotherapy in prostate cancer

Assessing vaccine-induced correlates of protection: Antigen-specific readouts versus system vaccinology

Prof. Ibtesam Kamel Afifi Professor of Medical Microbiology & Immunology

6/7/17. Immune cells. Co-evolution of innate and adaptive immunity. Importance of NK cells. Cells of innate(?) immune response

MHC MULTIMER PROFICIENCY PANEL 2017

Therapeutic efficacy of MUC1- specific CTL and CD137 costimulation. mammary cancer model. Pinku Mukherjee & Sandra Gendler

Effector mechanisms of cell-mediated immunity: Properties of effector, memory and regulatory T cells

Progressive Telomere Shortening of Epstein-Barr Virus Specific Memory T Cells during HIV Infection: Contributor to Exhaustion?

CONTRACTING ORGANIZATION: Johns Hopkins University School of Medicine Baltimore, MD 21205

The T cell receptor for MHC-associated peptide antigens

Adaptive Immune Response Day 2. The Adaptive Immune Response

I. Critical Vocabulary

Cellular Immunity in Aging and HIV: Correlates of Protection. Immune Senescence

- Defined as approaches that enhance, suppress or modify the immune system to treat or cure diseases.

New technologies for studying human immunity. Lisa Wagar Postdoctoral fellow, Mark Davis lab Stanford University School of Medicine

Administration of Tumor-Specific Cytotoxic T Lymphocytes Engineered to Resist TGF-ß to Patients with EBV-Associated Lymphomas

Immunology CANCER IMMUNOLOGY

Dendritic cell subsets and CD4 T cell immunity in Melanoma. Ben Wylie 1 st year PhD Candidate

Transcription:

Cytotoxicity assays Rory D. de Vries, PhD 1 1 Viroscience lab, Erasmus MC, Rotterdam, the Netherlands

Anti-influenza immunity Humoral / CD4+ / CD8+ / NK?

Function of CTL Elimination of virus-infected cells? Function of CTL is to eliminate virus-infected cells By lysis and induction of apoptosis through release of perforin, granzyme and FasLexpression Release of cytokines, e.g. IFNg and TNFa Recognition by CTL is MHC class I restricted

Anti-influenza CTL CTL as correlate of protection in humans

Detection of CTL Virus-specific CTL detection Proliferation of virus-specific CTL 3H-thymidine incorporation CFSE dilution assay Functional properties of virus-specific CTL Lytic activity ( 51 Cr classic) Cytokine production Activation markers Epitope specificity Peptides Multimers of MHC class I / peptide complex All of the above

Detection of CTL Virus-specific CTL detection Proliferation of virus-specific CTL 3H-thymidine incorporation CFSE dilution assay Functional properties of virus-specific CTL Lytic activity Cytokine production Activation markers Epitope specificity Peptides Multimers of MHC class I / peptide complex All of the above

CFSE dilution assay In vitro proliferation of antigen-specific T cells 5,6-CarboxyFluorecein diacetate Succinimidyl Ester (CFSE) labelling

CFSE dilution assay Advantages and disadvantages Advantages Easy to perform Flow cytometry Allows identification of cells Functional profile and differentiation No use of isotopes Disadvantages Identifies proliferating cells only Bystander activation?

Detection of CTL Virus-specific CTL detection Proliferation of virus-specific CTL 3H-thymidine incorporation CFSE dilution assay Functional properties of virus-specific CTL Lytic activity ( 51 Cr classic) Cytokine production Activation markers Epitope specificity Peptides Multimers of MHC class I / peptide complex All of the above

Alternatives to 51 Cr Classical 51 Cr release assay has only disadvantages Since the 51 Cr release assay has only disadvantages, alternatives: Flow cytometric methods CD107a degranulation assay Label target cells with fluorescent dyes, add effectors, measure target cell viability FATT-CTL Viral clearance assay

Lytic activity of CTL CD107a expression, marker for degranulation

Lytic activity of CTL FATT-CTL Fluorescent-antigen-transfected target (FATT) cells CTL assay Nucleofection into target cell by electroporation Target cell expressing antigen of interest detectable by flow cytometry 488nm Antigen-encoding gene in eukaryotic expression vector including GFP

Lytic activity of CTL FATT-CTL Cytotoxicity (target cell destruction) TCR 488 nm 635 nm TOPRO-3 MHC-I FITC detector APC detector

Lytic activity of CTL FATT-CTL TP3 % eliminated from live gate GFP Effectors: Targets: Antigen: Flu NP CD8+ T cell clone HLA-matched PBMC pnp01-gfp / ptat-gfp

Lytic activity of CTL FATT-CTL ex vivo without prior expansion!

FATT CTL assay Advantages and disadvantages Advantages No use of isotopes Endogenous antigen processing No use of peptides Endogenous antigen presentation No autologous cell lines required PBMC as target cells Advantages Sensitive Prolonged incubation times allow detection of lytic activity without prior expansion of T cells Frequency must be high Chronic infections No need for HLA typing Use of easy to prepare plasmids No viral vectors required

Alternative: Viral clearance / suppression assay Set-up for measles expressing reporters, could be adapted for influenza Many publications on influenza viruses expressing reporter genes Advantage over FATT-CTL: No construction of plasmids Context of live viral infection Easier to perform Disadvantage over FATT-CTL: Less standardization friendly

Alternative: Viral clearance assay

Alternative: Viral clearance assay

Alternative: Viral clearance assay

Considerations Different assays available, perform which assay? Many different techniques available: Considerations: Prior expansion / stimulation in vitro allowed YES / NO Antigen used for stimulation PEPTIDE / PROTEIN / VIRUS Immunodominant epitopes NO / YES, which HLA type KNOWN / UNKNOWN Exposure history KNOWN / UNKNOWN Phenotyping of cells required YES / NO